| | | | | |
| $44,0500 | -1,89% | $292,68M | $32,78K | |
NUCL Eagle Nuclear Energy Corp. Common stock | $9,7400 | +1,25% | $292,53M | $133,78K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,6000 | +2,22% | $292,20M | $4,14M | |
FWDI Forward Industries, Inc. Common Stock | $4,2100 | -0,94% | $292,06M | $899,28K | |
ELDN Eledon Pharmaceuticals, Inc. Common Stock | $3,9400 | +1,55% | $291,76M | $1,31M | |
| $9,3300 | -1,37% | $291,70M | $1,17M | |
SVAQ Silicon Valley Acquisition Corp. Class A Ordinary Shares | $10,0600 | -0,20% | $291,56M | $43,49K | |
WNEB Western New England Bancorp, Inc. | $14,2950 | +0,04% | $291,41M | $38,40K | |
| $7,9600 | +0,89% | $291,40M | $142,39K | |
PACH Pioneer Acquisition I Corp Class A Ordinary Shares | $10,2400 | +0,10% | $291,22M | $30,17K | |
MMD NYLI MacKay DefinedTerm Muni Opportunities Fund | $15,5000 | -0,32% | $291,08M | $80,41K | |
AENT Alliance Entertainment Holding Corporation Class A Common Stock | $5,8500 | -2,01% | $291,06M | $7,37K | |
GLSI Greenwich LifeSciences, Inc. | $23,4500 | +0,86% | $290,62M | $127,45K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3,9000 | +0,00% | $290,56M | $413,89K | |
TLSI TriSalus Life Sciences, Inc. Common Stock | $4,5550 | -3,90% | $290,50M | $186,12K | |
